Telocinobufagin was evaluated outside the cancer context in LLC-PK1 porcine kidney epithelial cell toxicity, and it was found to inhibit Wnt/β-catenin signaling via modulation of GSK3β activity, although AKT involvement was not evaluated. This evidence concerns the gene AKT1 and cancer.